- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02385942
KT(KT Corporation)-SNUBH(Seoul National University Bundang Hospital) U-health Cooperative Research
KT-SNUBH U-health Cooperative Research: Target Selection and Consumers' Intention Research for Commercialization of the Pressure Ulcer Management u-Health Solution
Study Overview
Detailed Description
In this study, 'the management of pressure ulcer' defined as procedures comprising wound assessment, wound dressing and infection control, visually evaluated the outcomes of 'the management of pressure ulcer' through the tele-consultation.
This study designed to draw service targets based on utility and compatibility of U-health solution service and to analyse whether health providers use U-health solution service.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gyeonggi-do
-
Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707
- Seoul National University Bundang Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject who has pressure ulcer or Health care provider for wound management
Exclusion Criteria:
- Subject who have Osteomyelitis
- Subject who have suppuration
- Subject who participated in other clinical trial within 30 days from screening date
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Tele-consultation system
compare the Live assessed wound size with the transmitted Smart phone-based wound size through Tele-consultation system
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
concordance rate of wound size between live assessed wound size and transmitted wound size
Time Frame: a week from post treatment
|
a week from post treatment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
concordance rate of wound size between live assessed wound size and transmitted wound size
Time Frame: 2 weeks from post treatment
|
2 weeks from post treatment
|
|
concordance rate of wound size between live assessed wound size and transmitted wound size
Time Frame: 3 weeks from post treatment
|
3 weeks from post treatment
|
|
concordance rate of wound size between live assessed wound size and transmitted wound size
Time Frame: 4 weeks from post treatment
|
4 weeks from post treatment
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Satisfaction degree of the tele-consultation as measured by questionnaire.
Time Frame: 4 weeks from post treatment
|
4 weeks from post treatment
|
|
Usability survey
Time Frame: 4 weeks from post treatment
|
4 weeks from post treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-1206/158-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.